4//SEC Filing
NOVAVAX INC 4
Accession 0001209191-15-050164
$NVAXCIK 0001000694operating
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 5:13 PM ET
Size
10.0 KB
Accession
0001209191-15-050164
Insider Transaction Report
Form 4
NOVAVAX INCNVAX
Modi Rajiv I.
Director10% Owner
Transactions
- Sale
Common Stock
2015-06-04$8.92/sh−65,589$585,054→ 3,495,319 total(indirect: See footnote) - Sale
Common Stock
2015-06-02$8.90/sh−84,092$748,419→ 3,915,908 total(indirect: See footnote) - Sale
Common Stock
2015-06-03$8.92/sh−355,000$3,166,600→ 3,560,908 total(indirect: See footnote)
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.90 to $8.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F2]These shares are owned directly by Satellite Overseas (Holdings) Limited, which is a wholly owned subsidiary (except for directors' qualifying shares) of Cadila Pharmaceuticals Ltd. Cadila Pharmaceuticals Ltd is an indirect beneficial owner of the reported securities. These shares are held for convenience in the name of "SOHL, Inc., as nominee for Satellite Overseas (Holdings) Limited." SOHL, Inc., has no voting, dispositive or pecuniary interest in any such shares.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.90 to $8.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.90 to $8.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Documents
Issuer
NOVAVAX INC
CIK 0001000694
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001000694
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 5:13 PM ET
- Size
- 10.0 KB